1. Home
  2. CRMT vs QNCX Comparison

CRMT vs QNCX Comparison

Compare CRMT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$18.31

Market Cap

208.2M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
167.0M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
CRMT
QNCX
Price
$18.31
$0.10
Analyst Decision
Buy
Hold
Analyst Count
2
3
Target Price
$37.00
$10.00
AVG Volume (30 Days)
75.6K
127.2M
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
N/A
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
$2.41
N/A
Revenue Next Year
$4.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.78
$0.09
52 Week High
$62.55
$4.55

Technical Indicators

Market Signals
Indicator
CRMT
QNCX
Relative Strength Index (RSI) 29.93 27.44
Support Level $17.78 N/A
Resistance Level $28.59 $0.98
Average True Range (ATR) 1.39 0.02
MACD -0.16 0.10
Stochastic Oscillator 16.16 12.47

Price Performance

Historical Comparison
CRMT
QNCX

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: